1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
0000-0002-0450-8907
Liu, G.
0000-0001-6781-367X
Ishida, Y.
0000-0001-9342-2525
Swapna, G.V.T.
Kleinfelter, S.
0000-0002-5792-8112
Koepnick, B.
0000-0001-7896-6217
Baker, D.
0000-0002-9440-3059
Montelione, G.T.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Nature
NATUAS
0006
1476-4687
570
390
394
10.1038/s41586-019-1274-4
31168091
De novo protein design by citizen scientists.
2019
10.2210/pdb6msp/pdb
pdb_00006msp
11725.060
De novo Designed Protein Foldit3
1
man
polymer
no
no
MGHHHHHHENLYFQSHMTDELLERLRQLFEELHERGTEIVVEVHINGERDEIRVRNISKEELKKLLERIREKIEREGSSE
VEVNVHSGGQTWTFNEK
MGHHHHHHENLYFQSHMTDELLERLRQLFEELHERGTEIVVEVHINGERDEIRVRNISKEELKKLLERIREKIEREGSSE
VEVNVHSGGQTWTFNEK
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
sample
1
97
32630
synthetic construct
83333
Escherichia coli K-12
Biological sequence
citation
citation_author
citation
database_2
pdbx_database_status
repository
Initial release
Data collection
Database references
Data collection
Database references
Database references
Other
1
0
2019-06-12
1
1
2019-06-19
1
2
2019-07-03
1
3
2023-06-14
_citation.country
_citation.journal_abbrev
_citation.journal_id_ASTM
_citation.journal_id_CSD
_citation.journal_id_ISSN
_citation.pdbx_database_id_PubMed
_citation.title
_citation.year
_citation.journal_volume
_citation.page_first
_citation.page_last
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_nmr_data
De novo Designed Protein Foldit3
N
RCSB
Y
RCSB
2018-10-17
REL
REL
REL
REL
target function
100
20
isotropic
1
3D 1H-13C NOESY
isotropic
1
3D 1H-15N NOESY
isotropic
1
3D HNCACB
isotropic
1
3D CBCA(CO)NH
isotropic
1
3D HNCO
isotropic
1
3D HCCH-TOCSY
isotropic
1
2D 1H-15N HSQC
isotropic
1
2D 1H-13C HSQC
0.3
mM
[U-13C; U-15N]
0.2
mM
condition_1
6.5
pH
1
atm
298
K
molecular dynamics
1
medoid
0.3 mM [U-13C; U-15N] foldit3, 90% H2O/10% D2O
The purified protein was dialyzed against 20 mM potassium phosphate (pH 6.5) and the protein concentration was adjusted to between 0.3-0.4 mM for NMR studies.
15N13C
90% H2O/10% D2O
solution
Brunger, Adams, Clore, Gros, Nilges and Read
refinement
CNS
Huang, Tejero, Powers and Montelione
refinement
AutoStructure
Guntert, Mumenthaler and Wuthrich
structure calculation
CYANA
Zimmerman, Moseley, Kulikowski and Montelione
chemical shift assignment
AutoAssign
Goddard
peak picking
Sparky
Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
processing
NMRPipe
Bruker Biospin
collection
TopSpin
600
Bruker
AVANCE III
MET
1
n
1
MET
1
A
GLY
2
n
2
GLY
2
A
HIS
3
n
3
HIS
3
A
HIS
4
n
4
HIS
4
A
HIS
5
n
5
HIS
5
A
HIS
6
n
6
HIS
6
A
HIS
7
n
7
HIS
7
A
HIS
8
n
8
HIS
8
A
GLU
9
n
9
GLU
9
A
ASN
10
n
10
ASN
10
A
LEU
11
n
11
LEU
11
A
TYR
12
n
12
TYR
12
A
PHE
13
n
13
PHE
13
A
GLN
14
n
14
GLN
14
A
SER
15
n
15
SER
15
A
HIS
16
n
16
HIS
16
A
MET
17
n
17
MET
17
A
THR
18
n
18
THR
18
A
ASP
19
n
19
ASP
19
A
GLU
20
n
20
GLU
20
A
LEU
21
n
21
LEU
21
A
LEU
22
n
22
LEU
22
A
GLU
23
n
23
GLU
23
A
ARG
24
n
24
ARG
24
A
LEU
25
n
25
LEU
25
A
ARG
26
n
26
ARG
26
A
GLN
27
n
27
GLN
27
A
LEU
28
n
28
LEU
28
A
PHE
29
n
29
PHE
29
A
GLU
30
n
30
GLU
30
A
GLU
31
n
31
GLU
31
A
LEU
32
n
32
LEU
32
A
HIS
33
n
33
HIS
33
A
GLU
34
n
34
GLU
34
A
ARG
35
n
35
ARG
35
A
GLY
36
n
36
GLY
36
A
THR
37
n
37
THR
37
A
GLU
38
n
38
GLU
38
A
ILE
39
n
39
ILE
39
A
VAL
40
n
40
VAL
40
A
VAL
41
n
41
VAL
41
A
GLU
42
n
42
GLU
42
A
VAL
43
n
43
VAL
43
A
HIS
44
n
44
HIS
44
A
ILE
45
n
45
ILE
45
A
ASN
46
n
46
ASN
46
A
GLY
47
n
47
GLY
47
A
GLU
48
n
48
GLU
48
A
ARG
49
n
49
ARG
49
A
ASP
50
n
50
ASP
50
A
GLU
51
n
51
GLU
51
A
ILE
52
n
52
ILE
52
A
ARG
53
n
53
ARG
53
A
VAL
54
n
54
VAL
54
A
ARG
55
n
55
ARG
55
A
ASN
56
n
56
ASN
56
A
ILE
57
n
57
ILE
57
A
SER
58
n
58
SER
58
A
LYS
59
n
59
LYS
59
A
GLU
60
n
60
GLU
60
A
GLU
61
n
61
GLU
61
A
LEU
62
n
62
LEU
62
A
LYS
63
n
63
LYS
63
A
LYS
64
n
64
LYS
64
A
LEU
65
n
65
LEU
65
A
LEU
66
n
66
LEU
66
A
GLU
67
n
67
GLU
67
A
ARG
68
n
68
ARG
68
A
ILE
69
n
69
ILE
69
A
ARG
70
n
70
ARG
70
A
GLU
71
n
71
GLU
71
A
LYS
72
n
72
LYS
72
A
ILE
73
n
73
ILE
73
A
GLU
74
n
74
GLU
74
A
ARG
75
n
75
ARG
75
A
GLU
76
n
76
GLU
76
A
GLY
77
n
77
GLY
77
A
SER
78
n
78
SER
78
A
SER
79
n
79
SER
79
A
GLU
80
n
80
GLU
80
A
VAL
81
n
81
VAL
81
A
GLU
82
n
82
GLU
82
A
VAL
83
n
83
VAL
83
A
ASN
84
n
84
ASN
84
A
VAL
85
n
85
VAL
85
A
HIS
86
n
86
HIS
86
A
SER
87
n
87
SER
87
A
GLY
88
n
88
GLY
88
A
GLY
89
n
89
GLY
89
A
GLN
90
n
90
GLN
90
A
THR
91
n
91
THR
91
A
TRP
92
n
92
TRP
92
A
THR
93
n
93
THR
93
A
PHE
94
n
94
PHE
94
A
ASN
95
n
95
ASN
95
A
GLU
96
n
96
GLU
96
A
LYS
97
n
97
LYS
97
A
author_defined_assembly
1
monomeric
gel filtration
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
GLU
48
A
O
GLU
48
A
N
ILE
45
A
N
ILE
45
A
N
GLU
42
A
N
GLU
42
A
O
ASN
84
A
O
ASN
84
A
N
VAL
83
A
N
VAL
83
A
O
PHE
94
A
O
PHE
94
1
A
HIS
3
-169.65
116.05
1
A
MET
17
-169.33
-53.02
1
A
ASP
19
-58.79
93.04
1
A
GLU
20
-145.85
-64.63
1
A
THR
37
-77.49
-169.92
1
A
GLU
38
-63.24
88.60
1
A
ASN
46
71.68
-72.05
1
A
ASN
56
63.40
73.76
2
A
HIS
5
-165.68
112.63
2
A
HIS
8
-152.00
58.84
2
A
HIS
16
-145.45
-27.26
2
A
MET
17
-91.95
55.41
2
A
THR
18
44.61
27.67
2
A
GLU
38
-57.78
100.74
2
A
ASN
56
56.15
83.65
3
A
HIS
4
-59.07
88.28
3
A
THR
18
70.98
-5.05
3
A
ASN
46
63.86
-71.93
3
A
ASN
56
58.79
82.85
3
A
GLU
80
-148.58
29.56
4
A
HIS
4
-69.15
97.84
4
A
HIS
6
50.11
13.62
4
A
LEU
11
-63.74
76.85
4
A
SER
15
-66.49
86.81
4
A
ARG
55
-122.19
-58.03
4
A
GLU
80
-162.20
94.95
5
A
HIS
8
-68.73
86.92
5
A
GLU
38
-58.59
86.54
5
A
ARG
55
-121.90
-85.33
6
A
HIS
4
-157.26
76.51
6
A
HIS
6
-161.66
79.07
6
A
HIS
7
-65.35
84.91
6
A
TYR
12
-126.22
-160.71
6
A
SER
15
57.69
71.80
6
A
GLU
20
-153.24
-57.16
6
A
GLU
38
-63.50
97.29
6
A
ASN
56
59.20
80.24
6
A
GLU
80
-84.61
41.42
7
A
HIS
4
-167.94
98.10
7
A
HIS
16
-133.26
-70.79
7
A
MET
17
-174.22
-179.24
7
A
THR
18
-143.22
31.37
7
A
GLU
20
-165.96
-57.49
7
A
ASN
56
66.70
88.52
8
A
ASN
56
51.89
77.26
8
A
GLU
76
-86.95
-75.94
9
A
GLU
38
-65.11
98.21
9
A
ASN
46
63.95
-74.52
9
A
ARG
55
-115.76
-92.15
9
A
ASN
56
-97.20
46.36
9
A
SER
87
-161.44
105.46
10
A
ARG
55
-105.95
-67.57
10
A
SER
87
-161.06
108.95
11
A
THR
18
-63.91
97.18
11
A
ARG
55
-127.62
-85.75
11
A
GLU
80
-153.53
85.39
12
A
PHE
13
-96.04
46.14
12
A
MET
17
62.57
90.38
12
A
ASP
19
75.65
-65.71
12
A
THR
37
50.47
171.12
12
A
ASN
56
61.18
87.76
13
A
HIS
8
67.31
110.95
13
A
PHE
13
-100.81
-80.10
13
A
GLN
14
69.49
-30.17
13
A
ARG
55
-121.02
-77.60
13
A
ASN
56
-98.46
41.23
13
A
GLU
96
-57.69
103.43
14
A
HIS
5
-135.71
-64.10
14
A
GLU
20
80.38
-49.36
14
A
ASN
46
72.05
-71.43
14
A
ARG
55
-126.43
-83.12
15
A
HIS
6
-68.76
98.52
15
A
HIS
7
-62.16
96.23
15
A
GLU
9
61.41
-72.43
15
A
SER
15
-64.11
96.50
15
A
THR
18
68.10
-69.24
15
A
ASN
46
67.79
-63.05
15
A
GLU
80
-63.93
86.82
16
A
HIS
7
-65.40
89.72
16
A
HIS
8
-69.92
-101.94
16
A
GLU
9
69.43
-25.33
16
A
LEU
11
76.02
-23.77
16
A
TYR
12
-72.88
-168.62
16
A
ASP
19
-159.90
-33.57
16
A
GLU
38
-65.15
86.56
16
A
ARG
55
-117.98
-80.25
16
A
ASN
56
-104.59
57.82
17
A
HIS
6
-69.69
80.52
17
A
HIS
7
-176.62
149.54
17
A
TYR
12
-123.10
-76.48
17
A
GLU
20
72.65
-11.23
17
A
GLU
38
-63.22
93.20
17
A
ARG
55
-123.97
-89.15
17
A
ASN
56
-92.99
37.73
17
A
SER
87
-161.30
101.84
19
A
HIS
3
-163.39
107.35
19
A
HIS
6
59.99
86.34
19
A
HIS
8
-149.13
54.92
19
A
ASN
10
-150.36
89.30
19
A
GLN
14
-58.58
105.61
19
A
ARG
55
-104.26
-65.60
19
A
GLU
76
-84.68
-76.58
19
A
SER
78
-100.63
-68.10
19
A
SER
79
176.65
-55.93
20
A
ASN
10
-49.64
101.44
20
A
GLN
14
-60.27
98.77
20
A
THR
18
-142.45
-22.66
20
A
GLU
20
-137.69
-63.77
20
A
SER
87
-160.46
104.12
N
De novo Designed Protein Foldit3
1
N
N
A
GLU
20
A
GLU
20
HELX_P
A
HIS
33
A
HIS
33
1
AA1
14
A
SER
58
A
SER
58
HELX_P
A
GLU
76
A
GLU
76
1
AA2
19
DE NOVO PROTEIN
de no designed foldit foldit3, DE NOVO PROTEIN
6MSP
PDB
1
1
6MSP
1
97
6MSP
1
97
6MSP
A
1
1
97
4
anti-parallel
anti-parallel
anti-parallel
A
GLU
48
A
GLU
48
A
ARG
55
A
ARG
55
A
GLU
38
A
GLU
38
A
ILE
45
A
ILE
45
A
VAL
81
A
VAL
81
A
SER
87
A
SER
87
A
GLN
90
A
GLN
90
A
ASN
95
A
ASN
95